Europe Nucleic Acid Isolation and Purification Market

The Europe nucleic acid isolation and purification market is projected to reach USD 2.41 billion by 2030 from USD 1.61 billion in 2025, at a CAGR of 8.4% during the forecast period. Major factors supporting growth in Europe nucleic acid isolation and purification market include sustained public funding and institutional investment in genomics, precision medicine, and life sciences research. Many regional and country-level programs continue to support growth in population genomics, cancer genomics, and rare disease testing, which in turn drives steady demand for extraction across both clinical and academic labs.

The Europe nucleic acid isolation and purification market is competitive. Prominent players in the market are Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Agilent Technologies, Inc. (US), and Merck KGaA (Germany), among others.

To know about the assumptions considered for the study download the pdf brochure

In September 2023, QIAGEN launched two new nucleic acid extraction kits: the QIAwave RNeasy Plus Mini Kit and QIAwave DNA/RNA Mini Kit, eco-friendlier versions of the RNeasy Plus Mini Kit and the All DNA/RNA Mini Kit. In August 2023, Danaher entered into a definitive agreement to acquire all the outstanding shares of Abcam. Through this development, Abcam is expected to operate as a standalone operating company within Danaher’s Life Sciences segment.

Thermo Fisher Scientific Inc. is a leading company in the Europe nucleic acid isolation and purification market. It has a diverse range of products, including the KingFisher automated purification systems designed for medium to high-throughput DNA and RNA extraction. The company’s strength is further enhanced by strong demand for consumables, particularly the MagMAX magnetic bead kits, which are designed for automation and used in various workflows, including viral/pathogen and routine extractions. For laboratories that continue to use manual and low to mid-throughput processes, Thermo Fisher also provides spin-column kits like PureLink and GeneJET for RNA and genomic DNA purification.

QIAGEN is another key player in the Europe nucleic acid isolation and purification market, supported by a strong sample-preparation portfolio utilized across clinical and research laboratories. Its growth is driven by QIAamp DNA workflows and RNeasy RNA kits, which are widely used for consistent high-quality nucleic acid purification across common sample types in the lab. Overall, QIAGEN’s mix of trusted kits and automation-ready platforms fits well with Europe’s focus on standardized workflows and repeatable results across multi-site lab networks.

F. Hoffmann-La Roche is a strong player in the Europe nucleic acid isolation and purification market, driven by its deep footprint in automated molecular testing labs. The company’s key strength is the MagNA Pure family, which includes the MagNA Pure 96 for high-throughput automated nucleic acid purification and the MagNA Pure 24, a fully automated clinical sample extractor. Roche also benefits from its cobas 6800/8800 systems, which offer an automated and integrated workflow for PCR-based nucleic acid testing, linking sample processing through result interpretation.

Market Ranking

The Europe nucleic acid isolation and purification market is competitive. Major suppliers grow in the market by integrating reliable chemistries, advanced automation systems, and meeting the ongoing demand for consumables. With its broad portfolio of magnetic bead- and column-based kits and extensive installed base of KingFisher systems in hospital labs, reference labs, and research centers, Thermo Fisher Scientific is a key company. QIAGEN continues to be a core benchmark player, driven by QIAamp and RNeasy kits and by automation platforms such as QIAsymphony and QIAcube that aid labs in standardizing extraction across sites. Roche is also a significant company in Europe, particularly in regulated clinical molecular testing, where laboratories prefer integrated, high-throughput workflows and rely on platforms like MagNA Pure and cobas to maintain turnaround times and ensure the quality of results. Across end users, purchasing decisions are shaped by reproducible yield, inhibitor control, and site-to-site consistency.

Related Reports:

Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com